mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.8 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |